Minutes - Medication WG 2021-03-02

From Health Level 7 Belgium Wiki
Attendees
  • Anne Nerenhausen
  • Annemieke Vergauwe
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi o
  • Hanne Vuegen o
  • Jan Lenie o
  • Jean-Louis Maggetto o
  • Jens Penny o
  • José Costa Teixeira
  • Karlien Erauw
  • Lars Vanreppelen o
  • Pablo Christiaens
  • Richard Francken o
  • Robin Bosman
  • Tom De Backer
  • Tom Henkens o
  • Will van Norel
Excused/Nor present
  • Jeroen De Wilde
  • Marc Buckens
  • Nils Devos
Agenda
  • examples of magistral preparations
  • feedback on vaccination FHIR profiling
  • feedback on medication record
Minutes
  • Magistral preparations: no update
  • New model of Medication record
  • medication is a snapshot
  • medication history is more complicated
  • Profiling for medication dispense: has not been requested in the FHIR validation meeting
  • new federal standards will be published in March (home care plan, allergy, vaccination, ...), dispense will not be included. It is ok to be included later in 2021. It can meanwhile be published at HL7 Belgium level
  • Vaccinations (part of RIZIV project) & international impact
  • Draft model for the medication record (we are not going to use the medication scheme as this is a reserved word in Belgium)
  • from architectural update
  • medication record could have the medication summary + details/facts (source data f.e. prescriptions, dispenses, vaccination records, adverse events, maybe allergy intolerances...)
  • all dispenses, even when not prescribed, should be part of the medication record
  • goal is not to implement this right now, but to foresee the possibilities, to make our architecture ready for the future
  • see draft proposal here
  • feedback:
  • medication dispenses are one source for the medication record, there are other sources
  • what exactly is the treatment line: f.e. hypertension includes several prescribed medications - will be different treatment line
  • aspirine can be taken on a regular basis (f.e. for blood thinning) and for ache (headache): treatment line gives the possiblity to have this in several treatment lines
  • it will depend by region whether there will be several treatment lines
  • if the treatment is exactly the same for several indications, no additional treatment line is needed
  • maybe indication has to be 1-many
  • this has a major impact on the medication scheme and the prescribing sources
  • business rules will have to be defined
  • medication record has the equivalent value of a care plan f.e. in Suisse
  • how does the medication scheme have to made up based on this: work item for next meeting
  • bring your own proposal
  • relations with current way of working


Next meeting March 2